cetrelimab,gemcitabine,tar-200
janssen
['mibc', 'cetrelimab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'tar-200', 'gemcitabine', 'bladder', 'imab ']
sunrise-4: tar-200 + cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with #mibc ineligible for or refuse neoadjuvant platinum-based chemotherapy. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology